New Issue-Abbott Laboratories sells $3 bln in debt

May 24 (BestGrowthStock) – Abbott Laboratories (ABT.N: ) on Monday
sold $3 billion of senior unsecured notes, said IFR, a Thomson
Reuters service.

Bank of America Merrill Lynch, JP Morgan, and Morgan
Stanley were the joint bookrunning managers for the sale.
BORROWER: ABBOTT LABORATORIES
TRANCHE 1
AMT $750 MLN COUPON 2.70 PCT MATURITY 5/27/2015
TYPE SR NOTES ISS PRICE 99.898 FIRST PAY 11/27/2010
MOODY’S A1 YIELD 2.722 PCT SETTLEMENT 5/27/2010
S&P DOUBLE-A SPREAD 70 BPS PAY FREQ SEMI-ANNUAL
FITCH A-PLUS MORE THAN TREAS MAKE-WHOLE CALL 10 BPS
TRANCHE 2
AMT $1 BLN COUPON 4.125 PCT MATURITY 5/27/2020
TYPE SR NOTES ISS PRICE 99.951 FIRST PAY 11/27/2010
MOODY’S A1 YIELD 4.131 PCT SETTLEMENT 5/27/2010
S&P DOUBLE-A SPREAD 90 BPS PAY FREQ SEMI-ANNUAL
FITCH A-PLUS MORE THAN TREAS MAKE-WHOLE CALL 15 BPS
TRANCHE 3
AMT $1.25 BLN COUPON 5.30 PCT MATURITY 5/27/2040
TYPE SR NOTES ISS PRICE 99.228 FIRST PAY 11/27/2010
MOODY’S A1 YIELD 5.325 PCT SETTLEMENT 5/27/2010
S&P DOUBLE-A SPREAD 122 BPS PAY FREQ SEMI-ANNUAL
FITCH A-PLUS MORE THAN TREAS MAKE-WHOLE CALL 20 BPS

Investment Basics

New Issue-Abbott Laboratories sells $3 bln in debt